Allan D. Levi, M.D., Ph.D., Robert M. Buck Distinguished Chair in Neurological Surgery at the University of Miami Miller School of Medicine, transplanted the first subject in the Phase II Pathway study assessing the efficacy of StemCells, Inc.’s proprietary human neural stem cells for the treatment of cervical spinal cord injuries. The first transplant was performed at the University of Miami Hospital at the Miller School of Medicine, home to The Miami Project To Cure Paralysis, one of the world’s most comprehensive spinal cord injury research centers dedicated to finding effective treatments for paralysis.
“Our center is a leader in clinical research aimed at curing paralysis, and we are excited to be participating in this approach to spinal cord injury repair. The first subject transplanted tolerated the procedure and is doing well,” said Levi, who is Principal Investigator for the study. “The Pathway study is designed to measure the potential of these human neural stem cells, HuCNS-SC, as a possible treatment for repairing some aspects of spinal cord injury.”
The Department of Public Health Sciences at the Miller School of Medicine and the University of Miami School of Architecture have been named charter members of the American Institute of Architects Design & Health Research Consortium, which will help fund basic research on how design affects public health.
Two researchers at the University of Miami Miller School of Medicine have received a $5.67 million four-year grant from the National Institute of Allergy and Infectious Diseases to continue their clinical trials of adult and pediatric patients with HIV/AIDS. It is the latest in a series of federal HIV/AIDS grants to the Miller School, dating back to 1986.
The University of Miami Miller School of Medicine has just launched a telemedicine program that provides doctors at Haiti’s only trauma, critical care and rehabilitation hospital with access to around-the-clock medical support through live video communication with UM trauma specialists.
A Sylvester Comprehensive Cancer Center neurosurgeon has used new visualization technology that makes a brain tumor glow, enabling a safer resection with less damage to normal brain tissue that surrounds it, offering hope to a seriously ill patient and his family.
Robert C. Fifer, Ph.D., associate professor and Director of Audiology and Speech-Language Pathology at the Mailman Center for Child Development, was recently honored with the American Speech-Language-Hearing Foundation’s prestigious Frank R. Kleffner Lifetime Clinical Career Award.